Premium
Phenotype, genotype and gender identity in a large cohort of patients from India with 5 α ‐reductase 2 deficiency
Author(s) -
Shabir I.,
Khurana M. L.,
Joseph A. A.,
Eunice M.,
Mehta M.,
Ammini A. C.
Publication year - 2015
Publication title -
andrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.947
H-Index - 43
eISSN - 2047-2927
pISSN - 2047-2919
DOI - 10.1111/andr.12108
Subject(s) - virilization , dihydrotestosterone , genotype , disorders of sex development , phenotype , testosterone (patch) , cohort , androgen , medicine , biology , endocrinology , genetics , gene , hormone
Summary Deficiency of the 5α‐reductase 2 enzyme impairs the conversion of testosterone to dihydrotestosterone (DHT) and differentiation of external genitalia, seminal vesicles and prostate in males. The present study describes the phenotype, genotype and gender identity in a large cohort of patients with 5αRD2. All patients underwent detailed clinical evaluation, hormonal profile, karyotyping and molecular analysis of the SRD5A2 gene. The molecular analysis of the SRD5A2 gene showed the presence of mutant alleles in 24 patients. We found 6 novel mutations IVS(1‐2) T>C, p.A52T, 188‐189insTA, 904‐905ins A, p.A12T and p.E57X in our patients. All patients had ambiguous genitalia and the degrees of under‐virilization ranged from penoscrotal hypospadias and microphallus to clitoromegaly. The position of gonads was variable in patients with same mutation. All the patients with mutations in the SRD5A2 gene had male gender identity. Those reared as female had gender dysphoria and underwent gender reassignment. Though a specific genotype–phenotype correlation could not be established in our patient but confirming the diagnosis of 5αRD2 with assessment of the SRD5A2 gene may help in appropriate gender assignment.